Home / CoEs / HealthPlus CoE
↟ CoE 10 / 18 · Healthcare & Pharmaceutical

HealthPlus CoE

Clinical AI, drug discovery and regulatory-affairs engineering — helping global healthcare and pharma companies build GxP-ready GCCs in India.

Healthcare & Pharmaceutical
8 wks Indicative FDA 21 CFR Part 11 readiness pathway
Day 1 GxP-capable workspace availability
200+ Pre-vetted clinical and health-tech specialists
5 Core healthcare & pharma practice areas
OUR CUSTOMERS

GoodWorks Group, trusted by everyone — Fortune 500 to startups.

EXPERT COMMITTEE

HealthPlus CoE Expert Committee

A 6–8 member committee brings together GCC leadership, domain specialists, technology experts and ecosystem perspectives. It provides strategic guidance, validates knowledge outputs and helps keep priority themes current.

HealthPlus CoE Expert Committee
The HealthPlus CoE Expert Committee convenes periodically
Industry Lead

Ex-CTO / Head of Digital — Healthcare GCC

Enterprise mandate, programme governance and GCC operating leadership.

Pharma R&D Lead

Drug Discovery / Computational Biology Lead

Deep delivery perspective across genomics, multi-omics and AI-assisted discovery.

Regulatory Specialist

FDA / EU MDR / ISO 13485 Specialist

Validates regulatory-affairs, quality-management and certification-readiness knowledge.

Clinical Data Lead

Clinical Data / Biostatistics Specialist

Brings CDISC, clinical-trial data science and real-world-data context.

Academia & Research

Healthcare & Pharmaceutical Research / University Representative

Connects applied research, specialist curricula and future-skills pipelines to healthcare & pharmaceutical capability building.

Government & Policy

Healthcare & Pharmaceutical Policy / Ecosystem Representative

Adds India policy, standards, investment and ecosystem-development context relevant to healthcare & pharmaceutical mandates.

Startup Ecosystem

Healthcare & Pharmaceutical Startup / Innovation Leader

Brings emerging technology, product innovation and specialist partner perspectives into the CoE agenda.

International SME

Global Healthcare & Pharmaceutical SME

Provides international benchmark, operating-model and capability-maturity perspective for global GCC programmes.

SECTOR OVERVIEW

India Healthcare & Pharma Engineering GCC Landscape

Bengaluru anchors a deep health-tech GCC cluster, while Hyderabad's Genome Valley strengthens India's position for drug-discovery and computational-biology mandates.

The HealthPlus CoE brings together clinical domain expertise, regulatory navigation across FDA, EU MDR, CDSCO and ISO 13485, GxP infrastructure knowledge and reusable GCC operating patterns for healthcare and pharmaceutical mandates.

8 wks FDA 21 CFR Part 11 readiness pathway
200+ Pre-vetted clinical & health-tech profiles
5 Core practice areas
1 Connected healthcare knowledge layer
REGULATORY LANDSCAPE

FDA 21 CFR Part 11

Electronic-records and e-signature validation requirements shape system, audit-trail and access-control design.

Tracked continuously

EU MDR / IVDR

Device and in-vitro-diagnostics regulation shapes technical-file, clinical-evidence and post-market obligations.

Tracked quarterly

ISO 13485 QMS

Quality-management-system requirements underpin repeatable, audit-ready engineering delivery for medical technology.

Tracked quarterly

CDSCO Medical Device Rules

India's device-approval framework continues to evolve, requiring ongoing regulatory monitoring for local and export mandates.

Tracked monthly

DPDP / HIPAA-aligned Data Handling

Health-data architecture must satisfy both India's DPDP Act and, where relevant, HIPAA-aligned expectations.

Tracked continuously
HOW THIS GCC COE DELIVERS VALUE
1

Knowledge

Healthcare & Pharmaceutical research, operating benchmarks, talent themes and priority standards are converted into decision-ready knowledge.

2

Advisory

Expert Committee guidance validates the capability model, operating choices and priority transformation themes for healthcare & pharmaceutical.

3

Ecosystem

Talent, technology, academic and specialist partner connections help accelerate healthcare & pharmaceutical capability building in India.

4

Accelerator Kit

Reusable blueprints, role maps, governance patterns and implementation playbooks reduce time spent designing the healthcare & pharmaceutical model from scratch.

SECTOR SNAPSHOT
India Healthcare & Pharma GCC Capability Snapshot
Pre-vetted Clinical Profiles
200+
Readiness Pathway
8 wks
Core Practice Areas
5
Regulatory Frameworks Tracked
5
Programme indicators reflect the published HealthPlus CoE proposition; enterprise-specific market and workforce metrics are validated separately.
THE CHALLENGE WE SOLVE

What global healthcare & pharma engineering teams need to solve

Healthcare and pharma GCCs need clinical compliance, GxP infrastructure and specialist talent designed in from day one, not retrofitted after audit findings.

01

FDA 21 CFR Part 11 Validation Complexity

Electronic-records and e-signature compliance needs specialist validation expertise that many generic GCC advisors do not carry.

02

GxP-Compliant Infrastructure Requirements

Validated systems, audit trails and, in some cases, clean-room capability need to be planned into the workspace before go-live.

03

Shortage of Clinical Data Management Talent

Clinical data managers with hands-on CDISC SDTM and ADaM experience can take three to four months to hire in the open market.

04

Constantly Evolving Regulatory Frameworks

CDSCO device rules and EU MDR requirements continue to change, so static compliance playbooks age quickly without monitoring.

05

Specialised Drug-Discovery Infrastructure

High-performance compute, multi-omics platforms and bioinformatics tooling often fall outside conventional enterprise-IT procurement.

OUR SERVICES — END-TO-END OR MODULAR

Build the right Healthcare & Pharmaceutical capability

Use the complete GCC lifecycle or select the strategy, setup, talent, technology, governance and transformation modules required for this mandate.

01

GCC Strategy & Business Case

Sector landscape, India clinical-talent analysis, Bengaluru vs Hyderabad comparison and HQ business case.

02

Regulatory Compliance Setup

FDA 21 CFR Part 11 framework, EU MDR/IVDR architecture, ISO 13485 QMS implementation and CDSCO navigation.

03

Entity & Legal Setup

Entity formation, DPIIT health-FDI facilitation, FEMA compliance and ABDM registration for health-data platforms.

04

Workspace — GxP-Capable Offices

GxP-ready managed offices with validated-system environments and clean-room specification options.

05

Talent Acquisition

Clinical data managers, biostatisticians, regulatory-affairs engineers, medical-imaging AI developers and FHIR architects.

06

Technology Platform Setup

Clinical-trial platform sandboxes, AWS HealthLake, FHIR R4 implementation and clinical-analytics environments.

07

Operating Model & Governance

Clinical team topology, GxP governance framework, regulatory-submission calendar and QMS design.

08

GCC REVIVE — Healthcare

Regulatory-posture recovery, GxP audit remediation and mandate reset for stalled health GCCs.

09

L&D — Domain Upskilling

CDISC, FDA 21 CFR, EU MDR, HL7 FHIR, pharmacovigilance and GxP-principles learning pathways.

HOW WE DELIVER

Three integrated layers

A common delivery model connects validated knowledge to setup, capability building, scale and ongoing optimisation.

01 / KNOWLEDGE

Knowledge & Expert Committee

Sector or functional research, operating intelligence, talent context, technology benchmarks, regulatory updates and reusable reference material.

02 / SETUP & BUILD

Setup & Build

Entity, workspace, talent, technology, compliance and operating-model setup aligned to the CoE mandate.

03 / GROWTH

Growth & Optimisation

Mandate expansion, capability upgrades, leadership development, health diagnostics and ongoing transformation advisory.

DOMAIN COVERAGE

What the HealthPlus GCC CoE Covers

Five practice areas span clinical technology, drug discovery, regulatory affairs, MedTech and healthcare data interoperability.

Clinical AI & Digital Health

Medical Imaging AI HL7 FHIR R4 Clinical NLP RWD Platforms

Drug Discovery & Comp. Biology

GenAI Drug Design Genomics Multi-omics CDISC SDTM/ADaM

Regulatory & QMS

FDA 21 CFR EU MDR / IVDR ISO 13485 CDSCO

MedTech & SaMD

IEC 62304 ISO 14971 Device Cybersecurity Wearable AI

Healthcare Data & Interop.

HIPAA-aligned Lakes PHI De-identification EDC Integration ABDM Exchange
ENGAGEMENT CADENCE

A repeatable rhythm of knowledge exchange

The model combines focused CoE activity with cross-ecosystem forums so knowledge stays current and actionable.

Per CoE — Semi-Annual Activity

Focused roundtables, working sessions and knowledge exchanges around the most material capability topics.

Annual Flagship Forum

A cross-CoE forum connecting enterprise leaders, experts, ecosystem partners and emerging capability themes.

KNOWLEDGE REPOSITORY

What HealthPlus CoE Publishes

A structured repository of reports, benchmarks, trackers, public snapshots and expert-led publications keeps the CoE knowledge layer current and practical.

QUARTERLY INTELLIGENCE

Healthcare & Pharmaceutical GCC Landscape Brief

Quarterly view of capability signals, operating trends, talent demand and material developments affecting healthcare & pharmaceutical GCC leaders.

Request access
BENCHMARK

Healthcare & Pharmaceutical Capability & Talent Benchmark

Role families, skill priorities, maturity indicators and operating benchmarks for planning and scale decisions.

Request access
PLAYBOOK

Healthcare & Pharmaceutical CoE Operating Playbook

Reusable governance, process, service-model and implementation patterns for enterprise teams.

Request access
SECTOR OVERVIEW

Healthcare & Pharmaceutical GCC Snapshot

Public high-level overview of the healthcare & pharmaceutical capability landscape, priority themes and India operating considerations.

View freely - no registration
WHITEPAPER

Healthcare & Pharmaceutical Strategy for India GCCs — 2026

A research-led perspective on building, scaling and transforming healthcare & pharmaceutical capability in India.

Request access
EXPERT BRIEFING

Healthcare & Pharmaceutical Expert Committee Briefing

Periodic expert-led briefing on material capability, talent, technology, governance and transformation themes.

View briefing details
ECOSYSTEM

Enterprise, academic and technology connections

The CoE connects capability leaders to the broader network required to establish, operate, scale and transform in India.

Enterprise & Industry

  • GCC and GBS leadership
  • Domain and functional specialists
  • Industry associations and peer networks

Academia & Research

  • Universities and research institutions
  • Specialist talent pipelines
  • Applied research and knowledge partnerships

Technology & Innovation

  • Technology platform specialists
  • Start-up and innovation ecosystem
  • International SMEs and benchmark networks
TECHNOLOGY PLATFORM

HealthPlus CoE AI Knowledge Assistant

Developed and maintained by Sansovi GCC, the assistant gives enterprises instant access to current, India-specific information sourced from the GCC CoE knowledge repository.

Sector-specific opportunities in India
Talent availability by vertical and role
Universities and research institutions
Government initiatives and infrastructure
Policy FAQs and investment environment
Events and ecosystem activities
GCC landscape and benchmarks
India's GCC ecosystem overview

Functions solely as an informational resource, never as legal, financial or regulatory advice.

HealthPlus CoE AI Knowledge Assistant interface
FREQUENTLY ASKED QUESTIONS

Common questions about HealthPlus CoE

Quick answers to the questions GCC leaders typically ask when evaluating this capability in India.

It governs electronic records and signatures — audit-trail-enabled systems, two-factor e-signature frameworks, IQ/OQ/PQ validation and role-based access controls, typically compatible with platforms such as Medidata Rave or Veeva Vault.

Bengaluru tends to lead for clinical AI, digital health and MedTech engineering, while Hyderabad's Genome Valley cluster favours drug discovery and computational biology; many mandates run a dual-city model.

CDISC defines the SDTM and ADaM data standards used in FDA/EMA clinical-trial submissions, so clinical data managers without CDISC experience cannot produce regulatory-grade datasets.

Ready to build your Centre of Excellence?

Whether you're establishing a new GCC capability, expanding an existing shared-services function, or moving toward AI-led intelligent operations — Sansovi GCC can help you assess, build and scale the right model.

SansoviGCC by GoodWorks Group is India’s Leading End-to-End GCC Solutions Platform to build, operate and scale GCCs.